HEADER TRANSFERASE 09-JUN-09 3HRB TITLE P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MITOGEN-ACTIVATED PROTEIN KINASE P38 ALPHA, MAP KINASE P38 COMPND 5 ALPHA, CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY DRUG-BINDING PROTEIN, COMPND 6 CSAID-BINDING PROTEIN, CSBP, MAX-INTERACTING PROTEIN 2, MAP KINASE COMPND 7 MXI2, SAPK2A; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 OTHER_DETAILS: THE PLASMID USED IS ANNOTATED AS SAREUM PROPRIETARY KEYWDS P38 MAP KINASE, TRANSFERASE, INHIBITOR COMPLEX, ALTERNATIVE SPLICING, KEYWDS 2 ATP-BINDING, CYTOPLASM, KINASE, NUCLEOTIDE-BINDING, NUCLEUS, KEYWDS 3 PHOSPHOPROTEIN, POLYMORPHISM, SERINE/THREONINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR V.SEGARRA,W.LUMERAS,B.VIDAL,P.LEONARD,M.FISHER,M.LAMERS REVDAT 3 01-NOV-23 3HRB 1 REMARK REVDAT 2 15-SEP-09 3HRB 1 JRNL REVDAT 1 01-SEP-09 3HRB 0 JRNL AUTH W.LUMERAS,F.CATURLA,L.VIDAL,C.ESTEVE,C.BALAGUE,A.ORELLANA, JRNL AUTH 2 M.DOMINGUEZ,R.ROCA,J.M.HUERTA,N.GODESSART,B.VIDAL JRNL TITL DESIGN, SYNTHESIS, AND STRUCTURE-ACTIVITY RELATIONSHIPS OF JRNL TITL 2 AMINOPYRIDINE N-OXIDES, A NOVEL SCAFFOLD FOR THE POTENT AND JRNL TITL 3 SELECTIVE INHIBITION OF P38 MITOGEN ACTIVATED PROTEIN KINASE JRNL REF J.MED.CHEM. V. 52 5531 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19678708 JRNL DOI 10.1021/JM9008604 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 82.6 REMARK 3 NUMBER OF REFLECTIONS : 19725 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1072 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2766 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.44000 REMARK 3 B22 (A**2) : -0.77000 REMARK 3 B33 (A**2) : 1.20000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.315 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.241 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.158 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.386 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.010 ; 0.022 REMARK 3 ANGLE DISTANCE (A) : 1.202 ; 1.972 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.005 ; 0.021 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.071 ; 0.200 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.718 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.333 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.441 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.402 ; 4.500 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3HRB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-JUN-09. REMARK 100 THE DEPOSITION ID IS D_1000053487. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54180 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.9 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20806 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 70.744 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.2 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : 0.05700 REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : 0.36700 REMARK 200 R SYM FOR SHELL (I) : 0.36700 REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1A9U REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% PEG 3350, 0.2M NACL, 0.1M BIS-TRIS REMARK 280 PH 6.5, 1MM THP, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.61000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.11500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.37500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.11500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.61000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.37500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 GLY A 31 REMARK 465 SER A 32 REMARK 465 GLY A 33 REMARK 465 ALA A 34 REMARK 465 TYR A 35 REMARK 465 LEU A 353 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 15 CG CD CE NZ REMARK 470 ARG A 57 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 118 CG CD CE NZ REMARK 470 ARG A 173 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 162 CB CYS A 162 SG -0.389 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 100 -36.66 -149.51 REMARK 500 ASN A 115 48.38 -62.50 REMARK 500 ILE A 116 -38.57 -177.50 REMARK 500 ARG A 149 -12.94 74.91 REMARK 500 CYS A 162 19.38 57.54 REMARK 500 ALA A 172 78.28 -117.83 REMARK 500 HIS A 199 101.18 -59.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I39 A 1 DBREF 3HRB A 2 360 UNP Q16539 MK14_HUMAN 2 360 SEQRES 1 A 359 SER GLN GLU ARG PRO THR PHE TYR ARG GLN GLU LEU ASN SEQRES 2 A 359 LYS THR ILE TRP GLU VAL PRO GLU ARG TYR GLN ASN LEU SEQRES 3 A 359 SER PRO VAL GLY SER GLY ALA TYR GLY SER VAL CYS ALA SEQRES 4 A 359 ALA PHE ASP THR LYS THR GLY LEU ARG VAL ALA VAL LYS SEQRES 5 A 359 LYS LEU SER ARG PRO PHE GLN SER ILE ILE HIS ALA LYS SEQRES 6 A 359 ARG THR TYR ARG GLU LEU ARG LEU LEU LYS HIS MET LYS SEQRES 7 A 359 HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL PHE THR PRO SEQRES 8 A 359 ALA ARG SER LEU GLU GLU PHE ASN ASP VAL TYR LEU VAL SEQRES 9 A 359 THR HIS LEU MET GLY ALA ASP LEU ASN ASN ILE VAL LYS SEQRES 10 A 359 CYS GLN LYS LEU THR ASP ASP HIS VAL GLN PHE LEU ILE SEQRES 11 A 359 TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER ALA SEQRES 12 A 359 ASP ILE ILE HIS ARG ASP LEU LYS PRO SER ASN LEU ALA SEQRES 13 A 359 VAL ASN GLU ASP CYS GLU LEU LYS ILE LEU ASP PHE GLY SEQRES 14 A 359 LEU ALA ARG HIS THR ASP ASP GLU MET THR GLY TYR VAL SEQRES 15 A 359 ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SEQRES 16 A 359 TRP MET HIS TYR ASN GLN THR VAL ASP ILE TRP SER VAL SEQRES 17 A 359 GLY CYS ILE MET ALA GLU LEU LEU THR GLY ARG THR LEU SEQRES 18 A 359 PHE PRO GLY THR ASP HIS ILE ASP GLN LEU LYS LEU ILE SEQRES 19 A 359 LEU ARG LEU VAL GLY THR PRO GLY ALA GLU LEU LEU LYS SEQRES 20 A 359 LYS ILE SER SER GLU SER ALA ARG ASN TYR ILE GLN SER SEQRES 21 A 359 LEU THR GLN MET PRO LYS MET ASN PHE ALA ASN VAL PHE SEQRES 22 A 359 ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU LEU GLU LYS SEQRES 23 A 359 MET LEU VAL LEU ASP SER ASP LYS ARG ILE THR ALA ALA SEQRES 24 A 359 GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN TYR HIS ASP SEQRES 25 A 359 PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR ASP GLN SER SEQRES 26 A 359 PHE GLU SER ARG ASP LEU LEU ILE ASP GLU TRP LYS SER SEQRES 27 A 359 LEU THR TYR ASP GLU VAL ILE SER PHE VAL PRO PRO PRO SEQRES 28 A 359 LEU ASP GLN GLU GLU MET GLU SER HET I39 A 1 25 HETNAM I39 [3-AMINO-2-(2-METHYLPHENYL)-1-OXIDOPYRIDIN-4-YL](2,4- HETNAM 2 I39 DIFLUOROPHENYL)METHANONE FORMUL 2 I39 C19 H14 F2 N2 O2 FORMUL 3 HOH *180(H2 O) HELIX 1 1 SER A 61 MET A 78 1 18 HELIX 2 2 THR A 123 ALA A 144 1 22 HELIX 3 3 LYS A 152 SER A 154 5 3 HELIX 4 4 ALA A 190 LEU A 195 1 6 HELIX 5 5 GLN A 202 GLY A 219 1 18 HELIX 6 6 ASP A 227 GLY A 240 1 14 HELIX 7 7 GLY A 243 ILE A 250 1 8 HELIX 8 8 SER A 252 GLN A 260 1 9 HELIX 9 9 ASN A 269 PHE A 274 1 6 HELIX 10 10 ASN A 278 LEU A 289 1 12 HELIX 11 11 ASP A 292 ARG A 296 5 5 HELIX 12 12 THR A 298 ALA A 304 1 7 HELIX 13 13 HIS A 305 ALA A 309 5 5 HELIX 14 14 GLN A 325 ARG A 330 5 6 HELIX 15 15 LEU A 333 SER A 347 1 15 SHEET 1 A 2 PHE A 8 LEU A 13 0 SHEET 2 A 2 THR A 16 PRO A 21 -1 O TRP A 18 N GLN A 11 SHEET 1 B 5 TYR A 24 PRO A 29 0 SHEET 2 B 5 SER A 37 ASP A 43 -1 O PHE A 42 N GLN A 25 SHEET 3 B 5 LEU A 48 LYS A 54 -1 O VAL A 52 N CYS A 39 SHEET 4 B 5 TYR A 103 HIS A 107 -1 O THR A 106 N ALA A 51 SHEET 5 B 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 C 3 ALA A 111 ASP A 112 0 SHEET 2 C 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 C 3 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 SITE 1 AC1 13 VAL A 30 VAL A 38 ALA A 51 LYS A 53 SITE 2 AC1 13 LEU A 75 LEU A 104 THR A 106 HIS A 107 SITE 3 AC1 13 LEU A 108 MET A 109 GLY A 110 ALA A 111 SITE 4 AC1 13 HOH A 402 CRYST1 45.220 86.750 122.230 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022114 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011527 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008181 0.00000